novartis-istock-641038488-photogearch-

photogearch / iStockphoto.com

13 April 2017Americas

Federal Circuit says Novartis invention is unpatentable

The US Court of Appeals for the Federal Circuit has affirmed a ruling of the Patent Trial and Appeal Board (PTAB) that a patent belonging to Novartis and Mitsubishi Pharma is obvious.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

Gilead scores win in fake HIV drug dispute

Polsinelli grows roster with ex-corporate counsel

‘Don’t rely on national case law’ at the UPC: Wouter Pors, Bird & Bird

Sandoz wins $137.2m payout for lost profits in generic launch

Sanofi signs global rights deal to develop rare cancer therapy

Unified Patent Court visualised: Cases, divisions, and classes in charts

WBD to merge with firm to create ‘powerhouse’ practice

‘Be prepared, and don’t assume at the UPC’: Christopher Stothers